§ PHARMACEUTICALS
USD · PharmaceuticalsALMS
ALUMIS INC
USDSector · Pharmaceuticals
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
110 increased/new, 65 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| AyurMaya Capital Management Company, LP | 15.1M | n/a | ±0% |
| BlackRock, Inc. | 7.2M | 0.0% | +57% |
| Deep Track Capital, LP | 6.8M | 2.4% | n/a |
| SAMSARA BIOCAPITAL, LLC | 6.3M | 13.6% | +10% |
| Foresite Capital Management V, LLC | 5.9M | 47.9% | +2% |
| venBio Partners LLC | 4.5M | 35.6% | −2% |
◇ AC INTELLIGENCE
Top institutional owners for ALMS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER13.9% · 0 holders
OTHER60.1% · 133 holders
PASSIVE / INDEX9.2% · 10 holders
DEALER / BANK6.5% · 18 holders
QUALITY / COMPOUNDER5.1% · 13 holders
SYSTEMATIC / QUANT1.8% · 9 holders
INCOME / DEFENSIVE1.7% · 12 holders
TACTICAL / MACRO1.2% · 4 holders
ACTIVIST0.5% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ALMS in the last 180 days.